Research has confirmed effectiveness of the company's Urox product formulation.
Seipel: Urox has undergone 20 years of research and development.
Urox is a superior formula for the neglected bladder supplement category.
M2 EQUITYBITES-October 4, 2016-Innovus Pharmaceuticals acquires rights to Urox for overactive bladder from Seipel Group
Pharmaceutical company Innovus Pharmaceuticals (OTCQB Venture Market:INNV) reported on Monday the signing of an exclusive licensing agreement with Seipel Group (SG) for the rights to market Urox Formulation using the company's Beyond Human Platform.
Innovus will market Urox Formulation under the name UriVaRx using its Beyond Human Platform.